5-Amino-1MQ Peptide for Laboratory Research

5-Amino-1MQ, chemically named 5-amino-1-methylquinolinium, is a methylated quinolinium small molecule investigated as an inhibitor of nicotinamide N-methyltransferase (NNMT). The catalogue label “5-amino-1mq peptide” names this small molecule, not a peptide. Its molecular architecture contains no amino-acid chain, peptide bond or amino-acid sequence. Catalogue placement and substance class are therefore separate matters.

The identity table deliberately keeps the 5-amino-1-methylquinolinium cation and the commonly referenced iodide form in separate rows. Each formula belongs only with its corresponding mass and PubChem record. These reference identifiers assist documentary reconciliation, but they do not identify the form represented by a supplied batch. That determination belongs to the applicable label, specification and batch-linked analytical record.

Research source: Neelakantan et al. 2018 · PMID 29155147 · DOI 10.1016/j.bcp.2017.11.007

The name 5-Amino-1MQ refers to the 5-amino-1-methylquinolinium cation. A commonly referenced iodide form pairs that cation with iodide, producing a distinct formula, mass and PubChem entry. A shared core name does not make the records interchangeable, and a literature reference to either record does not establish which form is present in supplied material.

Database identity, experimental material and delivered material answer different questions. A database record defines a reference entity; a publication describes material used under its reported conditions; a batch record connects the supplied sample to its specification and analytical results. No one layer substitutes for the others. This separation prevents an identifier from becoming an unsupported product specification. The physical presentation is likewise an open point to be established by approved product records rather than inferred from the small-molecule class or from market conventions.

Research source: Neelakantan et al. 2018 · PMID 29155147

This section describes findings in controlled research and keeps every observation attached to its model, intervention and comparator. Of the three cited publications, only Neelakantan 2018 directly examined 5-Amino-1MQ in a 3T3-L1 adipocyte culture and a preclinical diet-induced-obesity mouse model. Kraus 2014 examined the target through genetic NNMT knockdown in a genetic knockdown mouse model, not through the compound.

Sources: Kraus et al. 2014 · PMID 24717514 · Neelakantan et al. 2018 · PMID 29155147 · Dimet-Wiley et al. 2022 · PMID 35013352

Chemical inhibition and genetic knockdown are different interventions. Neelakantan 2018 examined 5-Amino-1MQ in a 3T3-L1 adipocyte culture and a preclinical diet-induced-obesity mouse model, whereas Kraus 2014 reduced NNMT genetically in a genetic knockdown mouse model. Evidence about the target from the genetic knockdown mouse model is not direct evidence about the compound, and agreement around NNMT does not erase differences in intervention, comparator or method.

Combined experimental conditions also restrict attribution. Dimet-Wiley 2022 assessed a caecal microbiome profile in a combined-condition mouse model that included both NNMT inhibition and a dietary switch. Because both conditions form part of the same combined-condition mouse model, the group comparison does not isolate each condition’s individual contribution.

Database identity, study identity and batch identity must remain separate. The cation and iodide entries describe reference records. The publications describe the experimental material and methods stated by their authors. Supplied material requires its own linked label, specification, batch code, sample reference, test date, methods and results. A matching catalogue name or database identifier alone does not determine counterion, physical presentation, purity or storage requirements.

The catalogue label can be documented without adopting its class implication. “5-amino-1mq peptide” is a catalogue label for a quinolinium small molecule that has no amino-acid chain, peptide bonds or sequence. The label, the actual chemical class and the identity of a supplied batch are three distinct documentary claims.

Evidence sources: Kraus et al. 2014 · PMID 24717514 · Neelakantan et al. 2018 · PMID 29155147 · Dimet-Wiley et al. 2022 · PMID 35013352

SKU 10AM identifies the catalogue record. The physical presentation, applicable salt form, storage conditions and stability period remain open points that require confirmation against approved product and batch documentation. None should be inferred from a database entry, publication, catalogue category or commonly referenced iodide record.

The documentation chain should connect the product designation, SKU 10AM, batch code, sample reference, test date, analytical method and reported result. HPLC may document chromatographic purity for the tested sample under the stated method, while a suitable MS result and coherent specification may provide complementary identity evidence. Any purity statement must remain specific to the documented batch. A released, batch-specific COA is therefore a requirement for reconciliation, not a characteristic asserted here for offered material.

For European laboratory procurement, published studies provide research context and batch records describe received material. The applicable label, released specification and analytical documentation should agree on identity and traceability before laboratory release. Scientific literature cannot replace that chain, and batch documentation cannot alter what a publication tested.

Research use only. For laboratory research only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Not a medicinal product, food or cosmetic.